Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opsens Inc T.OPS

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.


TSX:OPS - Post by User

Comment by retiredcfon May 23, 2023 6:40am
150 Views
Post# 35459725

RE:Update needed

RE:Update needed
Qccity1 wrote: Opsens is more than due for an update: Number of sites using Savvy in NA. State on Europe approval. Contracts signed with hospitals and new Buying Groups. Update on Clinical Studies. Update on Industrial and Aerospace potential. Overall feedback from clinicians regarding use of both wires.  Other important developments like competition and pricing.
New CFO could jump in...
GLTA


With all due respect, I would disagree. If you look at what OPS have done over the years, they are doing exactly the same as always. Announced record earnings in January and again only 6 weeks ago. Provide updates on SavvyWire and which conferences they are attending and/or presenting, etc. 

The only difference this time round is that the SP is struggling. But OPS is one of a multitude of companies in the same boat. As I'm sure everyone is aware, the market (and investors) are very skittish these days worried about the US debt ceiling, rising inflation and interest rates, the war in Ukraine, Chinese sabre rattling etc. As a result, small caps in particular have been hammered and in many cases (like OPS) for no reasons other than general nervousness about the "BIg Picture" .

If you need the money now then you have a problem. If not, then hang in there. The old saying that the market can remain irrational longer than the investor can remaln solvent has never been more applicable. Investing requires good DD, patience, a very thick skin, and a sense of humour.  And frequently it can be a pain in the a** but if it was easy, everyone would be a millionaire. GLTA

<< Previous
Bullboard Posts
Next >>